Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
KZIA
Stock Latest News
Company Announcements
Kazia Therapeutics Licenses SETDB1 Epigenetic Platform to Bolster Oncology Pipeline
1d ago
6K
KZIA
Premium
The Fly
Kazia Therapeutics in-licenses drug development platform from QIMR Berghofer
1d ago
KZIA
Premium
Company Announcements
Kazia Therapeutics Announces Board Changes and AGM Outcomes as It Highlights Oncology Pipeline
14d ago
6K
KZIA
Premium
Company Announcements
Kazia Therapeutics Taps Leerink for New ATM Facility as Cash Bolstered by Late-2025 PIPE
16d ago
6K
KZIA
Premium
Company Announcements
Kazia Therapeutics Posts Wider Half-Year Loss but Bolsters Cash, Pipeline and Nasdaq Compliance
26d ago
6K
KZIA
Premium
The Fly
Kazia Therapeutics’ NDL2 shows anti-tumor efficacy in preclinical data
2M ago
KZIA
Premium
The Fly
Four new option listings and one option delisting on January 28th
3M ago
KZIA
MICC
Premium
Company Announcements
Kazia Therapeutics Posts Early Efficacy Signals for Paxalisib Combo in Metastatic Triple-Negative Breast Cancer
3M ago
6K
KZIA
Premium
The Fly
Kazia Therapeutics’ paxalisib shows clinical response in Phase 1b breast cancer
3M ago
KZIA
Premium
The Fly
Kazia Therapeutics trading resumes
3M ago
KZIA
Premium
The Fly
Kazia Therapeutics trading halted, volatility trading pause
3M ago
KZIA
Premium
The Fly
Kazia Therapeutics regains Nasdaq compliance
4M ago
KZIA
Premium
The Fly
Kazia Therapeutics files to sell 10.7M American depositary shares for holders
4M ago
KZIA
Premium
Company Announcements
Kazia Therapeutics Retains Nasdaq Listing After Regaining Compliance
4M ago
6K
KZIA
Premium
The Fly
Kazia Therapeutics price target raised to $18 from $13 at H.C. Wainwright
4M ago
KZIA
Premium
Company Announcements
Kazia Therapeutics Unveils Promising Paxalisib Data at Breast Cancer Symposium
4M ago
6K
KZIA
Premium
The Fly
Kazia Therapeutics announces presentation from paxalisib studies
4M ago
KZIA
Premium
Company Announcements
Kazia Therapeutics Secures $46.5 Million Through Private Placement to Address Nasdaq Compliance
4M ago
6K
KZIA
Premium
Company Announcements
Kazia Therapeutics Secures $50 Million in Private Placement to Advance Cancer Drug Development
4M ago
6K
KZIA
Premium
The Fly
Kazia Therapeutics trading resumes
4M ago
KZIA
Premium
The Fly
Kazia Therapeutics trading halted, volatility trading pause
4M ago
KZIA
Premium
The Fly
Kazia Therapeutics announces pricing of $50M private placement
4M ago
KZIA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
